Events

FSVP Enforcement Expected to Accelerate

FSVP Enforcement Expected to Accelerate

It’s been eight years since the Food Safety Modernization Act (FSMA) was signed into law. With that, the U.S. Food and Drug Administration (FDA) started issuing new regulations designed to strengthen the food safety system. At the same time, they took the “educate...

read more
FDAImports Welcomes New Affiliated Attorney

FDAImports Welcomes New Affiliated Attorney

Our team of associated attorneys Strengthens Resources The consulting practice FDAImports (http://www.fdaimports.com) announced today that Thomas J. O’Donnell has joined our group of affiliated attorneys to further develop their growing portfolio of regional and...

read more
USTR Tariffs Expanded to $200 billion worth of Chinese Products

USTR Tariffs Expanded to $200 billion worth of Chinese Products

 Yesterday the White House announced another round of tariffs on Chinese imports which will become effective September 24, 2018. This round of tariffs (referred to as “List 3”) was proposed in July and includes human and animal foods and ingredients, cosmetics, and...

read more

FDAImports.com and AMCHAM Colombia

In October, FDAImports.com Partner Rick Quinn attended an event with the American Chamber of Commerce in Colombia and spoke about the regulatory basics of exporting to the United States. Mr. Quinn explained the regulatory agencies involved in imports in the U.S.,...

read more

GDUFA Fees Increased – and Won’t Stop Anytime Soon

While generic drug laws and policy have brought down the cost of Rx drugs for many Americans, recent legislation, such as the Generic Drug User Fee Amendments of 2012 (GDUFA) is reversing that trend and significantly increasing the cost of generic drugs.  GDUFA added...

read more

Successful Webinar: Preventive Care for Import Compliance

Benjamin England, FDAImports.com Founder and CEO recently presented a webinar with FDANews, entitled “Thinking Ahead of FDA: Preventive care tips for your FDA import compliance program.” Mr. England said, “Up to now, FDA has been mostly reactionary in its enforcement...

read more

Subscribe To Our Blog!

Get up-to-date industry and regulatory news from the experts delivered straight to your inbox.

Thanks! You have been successfully subscribed.